concurrent chemoradiotherpay
Showing 1 - 25 of 2,089
NSCLC Trial in Guangzhou (Hypofractionated radiotherapy, induction chemo-immunotherapy, concurrent chemo)
Recruiting
- Non-small Cell Lung Cancer
- Hypofractionated radiotherapy
- +4 more
-
Guangzhou, Guangdong, ChinaSun yat-sen university cancer center
Nov 14, 2023
Locally Advanced, NSCLC Trial in Shanghai (drug, procedure, radiation)
Recruiting
- Locally Advanced
- Non-small Cell Lung Cancer
- Serplulimab
- +5 more
-
Shanghai, ChinaShanghai Pulmonary Hospital
Mar 14, 2023
Aging Trial in Porto Alegre (Traditional concurrent training, Concurrent training consisting of strength training combined with
Recruiting
- Aging
- Traditional concurrent training
- Concurrent training consisting of strength training combined with dance classes
-
Porto Alegre, Rio Grande Do Sul, BrazilEscola de Educação Física, Fisioterapia e Dança - UFRGS
May 11, 2023
Esophageal Cancer Trial in Tianjin (Arm A, Arm B)
Not yet recruiting
- Esophageal Cancer
- Arm A
- Arm B
-
Tianjin, Tianjin, ChinaTianjin Cancer Hospital
Sep 24, 2023
Small Cell Lung Cancer Trial in Worldwide (biological, drug, radiation)
Recruiting
- Small Cell Lung Cancer
- Pembrolizumab 200 mg
- +8 more
-
Chandler, Arizona
- +170 more
Feb 2, 2023
Type 2 Diabetes With Peripheral Angiopathy Trial in Karachi (Concurrent Training, Aerobic Training)
Enrolling by invitation
- Type 2 Diabetes With Peripheral Angiopathy
- Concurrent Training
- Aerobic Training
-
Karachi, Sindh, PakistanUroosa Amin
Sep 7, 2023
Nasopharyngeal Carcinoma Trial in Fuzhou (without concurrent cisplatin chemo, with concurrent cisplatin chemo)
Not yet recruiting
- Nasopharyngeal Carcinoma
- without concurrent cisplatin chemotherapy
- with concurrent cisplatin chemotherapy
-
Fuzhou, Fujian, ChinaDepartment of radiation oncology, Fujian cancer hospital
Oct 18, 2023
NSCLC, Consolidation Immunotherapy, Radiotherapy or Sequential Chemoradiation Trial in Beijing (Tislelizumab)
Recruiting
- Non-small Cell Lung Cancer
- +2 more
-
Beijing, ChinaPeking University Cancer Hospital and Institute
Mar 4, 2023
Chronic Hepatitis B, Non-alcoholic Fatty Liver Disease Trial in Taipei (exercise)
Enrolling by invitation
- Chronic Hepatitis B
- Non-alcoholic Fatty Liver Disease
- exercise
-
Taipei, Zhongzheng Dist., TaiwanNational Taiwan University Hospital
Jul 13, 2023
Locally Advanced Nasopharyngeal Carcinoma Trial in Guangzhou (2 cycles induction chemo, 3 cycles induction chemo)
Recruiting
- Locally Advanced Nasopharyngeal Carcinoma
- 2 cycles induction chemotherapy
- 3 cycles induction chemotherapy
-
Guangzhou, Other (Non U.s.), ChinaFirst Affiliated Hospital, Sun Yat-Sen University
May 6, 2023
Esophageal Cancer Trial (Hypofractionated radiotherapy)
Not yet recruiting
- Esophageal Cancer
- Hypofractionated radiotherapy
- (no location specified)
Jan 18, 2023
Limited-Stage Small Cell Lung Cancer Trial in Jinan (HLX10, carboplatin/cisplatin-etoposide, Thoracic radiotherapy)
Recruiting
- Limited-Stage Small Cell Lung Cancer
- HLX10
- +4 more
-
Anaheim, California
- +83 more
Jan 12, 2023
Lung Tumors, NSCLC Trial in Worldwide (biological, drug, radiation)
Recruiting
- Lung Neoplasms
- Carcinoma, Non-Small-Cell Lung
- Pembrolizumab
- +9 more
-
Mobile, Alabama
- +194 more
Aug 18, 2022
Lung Tumors Trial (Envafolimab combined with concurrent chemoradiotherapy (Hypofractionated radiotherapy), Envafolimab combined
Not yet recruiting
- Lung Neoplasms
- Envafolimab combined with concurrent chemoradiotherapy (Hypofractionated radiotherapy)
- Envafolimab combined with concurrent chemoradiotherapy (Conventional Radiotherapy)
- (no location specified)
Jun 12, 2023
Pancreatic Carcinoma Trial in Nanjing (Toripalimab, Gemcitabine, Nab paclitaxel)
Not yet recruiting
- Pancreatic Carcinoma
- Toripalimab
- +3 more
-
Nanjing, Jiangsu, ChinaThe Affiliated Nanjing Drum Tower Hospital of Nanjing University
Oct 6, 2023
Non Small Cell Lung Cancer Trial in Salt Lake City (radiation, device, drug)
Not yet recruiting
- Non Small Cell Lung Cancer
- carboplatin chemotherapy
- +2 more
-
Salt Lake City, UtahHuntsman Cancer Institute
Nov 3, 2023
Locally Advanced Cervical Carcinoma Trial in China (AK104, EBRT, BT)
Recruiting
- Locally Advanced Cervical Carcinoma
- AK104
- +4 more
-
Beijing, Beijing, China
- +9 more
Aug 22, 2022
Nasopharyngeal Carcinoma Trial in Shanghai (Radiotherapy, Cisplatin)
Recruiting
- Nasopharyngeal Carcinoma
-
Shanghai, Shanghai, ChinaFudan Universtiy Shanghai Cancer Centre
Jan 7, 2023
Nasopharyngeal Carcinoma, Iron-deficiency, Anemia Trial in Guangzhou (Iron Isomaltoside 1000, Polysaccharide Iron Complex Pill,
Recruiting
- Nasopharyngeal Carcinoma
- +2 more
- Iron Isomaltoside 1000
- +2 more
-
Guangzhou, Guangdong, ChinaDepartment of Nasopharyngeal Carcinoma, Sun Yat-sen University C
Jun 19, 2023
Soft Tissue Sarcoma Trial in Beijing (Fluzoparib, Preoperative moderately fractionated radiotherapay)
Recruiting
- Soft Tissue Sarcoma
- Fluzoparib
- Preoperative moderately fractionated radiotherapay
-
Beijing, Beijing, China
- +1 more
Jul 3, 2023
Esophageal Cancer, Intensity-modulated Radiation Therapy, Concurrent Chemoradiotherapy Trial in Beijing (rhTPO)
Not yet recruiting
- Esophageal Cancer
- +3 more
-
Beijing, Beijing, ChinaDepartment of Radiation Oncology, Cancer Institute and Hospital,
Jul 12, 2023
Arthritis, Psoriatic Arthritis Trial (Mobile Application)
Not yet recruiting
- Arthritis
- Psoriatic Arthritis
- Mobile Application
- (no location specified)
Aug 22, 2023
Head and Neck Tumors Trial in Nanjing (Tislelizumab, Paclitaxel (albumin-bound type), Cisplatin, 5-FU)
Recruiting
- Head and Neck Tumors
- Tislelizumab, Paclitaxel (albumin-bound type), Cisplatin, 5-FU
-
Nanjing, Jiangsu, ChinaDepartment of Oncology, Drum Tower Hospital, Nanjing University
Feb 24, 2023